Ozempic, containing semaglutide, is an injectable medication from Novo Nordisk, designed to manage type 2 diabetes. This GLP-1 receptor agonist effectively lowers blood glucose levels by mimicking incretin hormones, improving glycemic control, and reducing A1C levels. It also slows gastric emptying, promoting a feeling of fullness that aids in weight loss, and provides cardiovascular benefits by